Skip to main content
Elsevier
View Cart
Your Account

Books in Pharmacoepidemiology

BooksJournals

Phytochemical Profiling of Commercially Important South African Plants

  • 1st Edition
  • August 28, 2021
  • Alvaro Viljoen + 4 more
  • English
  • Hardback
    9 7 8 - 0 - 1 2 - 8 2 3 7 7 9 - 3
  • eBook
    9 7 8 - 0 - 1 2 - 8 2 3 7 8 0 - 9
Phytochemical Profiling of Commercially Important South African Plants comprises a carefully selected group of plant species that are of interest to researchers and industry partners who would like to investigate the commercialization of plant species. The book presents 25 botanicals selected based on commercial relevance. For each of the species, the following topics are covered: botanical description and distribution, phytochemistry (including chemical structures), HPTLC fingerprint analysis, UPLC analysis, and GC analysis (the latter only in the case of essential oil-bearing species). Using standard methodology, high-level chromatographic fingerprints have been developed for better understanding. Different methods are succinctly summarized allowing for the rapid identification of botanical raw materials and formulated consumer products. This book will be extremely valuable to researchers in the field who wish to rapidly identify the constituents and for those who want to prepare formulations of plant material for commercial applications. This work will also be a valuable resource in the field of pharmacognosy.

Tailor-Made Polysaccharides in Biomedical Applications

  • 1st Edition
  • February 15, 2021
  • Amit Kumar Nayak + 2 more
  • English
  • Paperback
    9 7 8 - 0 - 1 2 - 8 2 1 3 4 4 - 5
  • eBook
    9 7 8 - 0 - 1 2 - 8 2 1 3 5 6 - 8
Tailor-Made Polysaccharides in Biomedical Applications provides extensive details on all the vital precepts, basics, and fundamental aspects of tailored polysaccharides in the pharmaceutical and biotechnological industries. This information provides readers with the foundation for understanding and developing high-quality products. The utilization of natural polymeric excipients in numerous healthcare applications demands the replacement of the synthetic polymers with natural polymers. Natural polymers are superior in terms of biocompatibility, biodegradability, economic extraction, and ready availability. Natural polymers are especially useful in that they are a renewable source of raw materials, as long as they are grown sustainably. Among these natural polymers, polysaccharides are considered as excellent excipients because they are nontoxic, stable, and biodegradable. Several research innovations have been carried out using polysaccharides in drug delivery applications. This book offers a comprehensive resource to understand the potential of these materials in forming new drug delivery methods. It will be useful to biomedical researchers, chemical engineers, regulatory scientists, and students who are actively involved in developing pharmaceutical products for biomedical applications by using tailor-made polysaccharides.

Pharmacoepidemiology and Pharmacovigilance

  • 1st Edition
  • October 17, 2018
  • Sabrina Nour + 1 more
  • English
  • Paperback
    9 7 8 - 0 - 1 2 - 8 1 6 1 8 3 - 8
  • eBook
    9 7 8 - 0 - 1 2 - 8 1 6 3 8 1 - 8
Pharmacoepidemiology and Pharmacovigilance: Synergistic Tools to Better Investigate Drug Safety examines the role of pharmacoepidemiologic studies in drug development and its use as a prevention tool in pharmacovigilance activities. The book introduces the various epidemiologic tools and study designs commonly used for the surveillance of drug-related adverse effects and reviews the strengths and weaknesses of each. Criticisms surrounding pharmacoepidemiologic research and issues that often interfere or complicate the conduct and interpretation of these studies are also explored. Case studies illustrate the passive and active surveillance of adverse drug reactions in clinical situations, covering important pharmacoepidemiologic concepts like health risk management and safety. The book helps pharmaceutical industry groups engaged in drug safety, clinical investigators, medical evaluators and those seeking regulatory approval enhance the safety of the drug development process for all patient populations.